Clinical Trials
Clinical Trials
Improving Clinical Trials
Schaeffer researchers evaluate ways to improve clinical trial data and get valuable innovation to market faster. Schaeffer also leads the Clinical Trial Recruitment Lab.
Related Topics
Top Stories View All
Comment Letter
Comments on FDA’s Proposed Expedited Investigational New Drug Pilot Program
Featured Experts: Lowell Schiller, Barry Liden
In The News View All
PharmaVoice
Kanter discusses the risks of a prolonged FDA commissioner vacancy
Featured Experts: Genevieve P. Kanter
WGBH
Kanter addresses psychedelics executive order and outlines concerns with the FDA commissioner’s voucher program
Featured Experts: Genevieve P. Kanter
The New York Times
Joyce discusses researchers’ efforts to study if statins can prevent dementia
Featured Experts: Geoffrey Joyce
Axios
Schiller says China’s rise in drug development could upend U.S. R&D models
Featured Experts: Lowell Schiller
STAT News
Kanter tracks decline in FDA public advisory committee meetings
Featured Experts: Genevieve P. Kanter
Featured Article
Lack of Diversity in Clinical Trials Costs Billions of Dollars. Incentives Can Spur Innovation
Economic incentives to recruit more diverse participants for clinical trials are available and could save the U.S. billions of dollars.
Experts: Dana Goldman
Clinical Trial Recruitment Lab
Piloting Novel Clinical Trial Recruitment Strategies
Schaeffer leads an interdisciplinary lab that pilots novel ways to improve recruitment and retention in clinical trials.
Clinical Trial Recruitment Lab